HighTower Advisors »

Structure Therapeutics shares owned by HighTower Advisors

Quarter-by-quarter ownership of Structure Therapeutics (GPCR) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Structure Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Structure Therapeutics held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Structure Therapeutics by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $648k 9.3k 69.55
2025-09-30 $252k 9.0k 28.00

More positions owned by HighTower Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl A (GOOGL)
Exxon Mobil Corporation (XOM)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Vanguard Index Fds Growth Etf (VUG)

View all positions for HighTower Advisors

Top funds holding Structure Therapeutics

venBio Select Advisor
Wellington Management Company
FMR
Henderson Group
Deep Track Capital
BVF
Baker Bros. Advisors
RA Capital Management
Principal Financial Group
Millennium Management
Casdin Capital
OrbiMed Advisors
Siren
TCG Crossover Management
Driehaus Capital Management

View all funds holding Structure Therapeutics